JADPRO Live 2018 Certified Educational Activities
Earn CE credit with these certified educational activities based on presentations from JADPRO Live at APSHO 2018. Access the full-length video presentation, the slide deck, transcript, and the entire lecture as a podcast. You can earn CE for each of these activities by following the links.
Click on any of the video presentations below to get started!
CAR T-Cell Therapy and the Pharmacology of Managing Cytokine Release Syndrome
Learn from two experts on how to identify patients who meet criteria as candidates for CAR T-cell therapy and apply strategies to mitigate associated serious side effects, including cytokine release syndrome.
Posted: January 31, 2019 / Expires: January 31, 2020
This certified activity has expired but you may watch the video without claiming credit.
Sequencing Therapies in Indolent Lymphomas (FL and CLL)
Discover current best practices for treating follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL), including monitoring patients with CLL for 17p deletion at diagnosis and throughout the course of the disease and current and emerging data supporting combination therapies in CLL and novel targeted therapies for newly diagnosed and relapsed/refractory FL.
Posted: January 31, 2019 / Expires: January 31, 2020
This certified activity has expired but you may watch the video without claiming credit.
Therapeutic Advances in Prostate Cancer
Learn from two experts in the field of prostate cancer as they discuss clinical data of emerging and current agents for the treatment of non-metastatic castration-resistant prostate cancer for rapidly rising prostate-specific antigen levels, the role of docetaxel and abiraterone in newly diagnosed metastatic disease, emerging data on the role of genomics in metastatic castration-sensitive and -resistant disease, and strategies to manage toxicities of current and emerging treatments.
Posted: January 31, 2019 / Expires: January 31, 2020
This certified activity has expired but you may watch the video without claiming credit.
Evolving Strategies to Manage Treatment-Related Adverse Events for Patients with Classical Hodgkin Lymphoma
Discover how to prevent and mitigate adverse events of established and emerging cytotoxic regimens, novel agents, and checkpoint inhibitors used to treat classical Hodgkin lymphoma, including best practices and emerging data.
Posted: January 31, 2019 / Expires: January 31, 2020
This certified activity has expired but you may watch the video without claiming credit.
New Directions in Myeloid Malignancies
Review strategies to monitor minimal residual disease in myeloid malignancies, as well as the safety and efficacy of novel treatment approaches and associated mutations such as IDH2, TP53, FLT3, BCL2, and cell surface antigen CD33.
Posted: January 31, 2019 / Expires: January 31, 2020
This certified activity has expired but you may watch the video without claiming credit.
Sequencing of Treatments for Patients With Ovarian Cancer
Take a deep dive into the history of ovarian cancer treatment, evaluate current options for first-line and maintenance therapy, and review safety and efficacy data for PARP inhibitors alone and in combination with immunotherapy or anti-angiogenic agents.
Posted: January 31, 2019 / Expires: January 31, 2020
This certified activity has expired but you may watch the video without claiming credit.
New Drug Updates in Hematologic Malignancies
Discover the latest pharmacology and indication approvals for the management of patients with hematologic malignancies, including pivotal clinical trial data, associated signs and symptoms of serious or life-threatening adverse effects, and the impact of these agents in advanced practice.
Posted: January 31, 2019 / Expires: January 31, 2020
This certified activity has expired but you may watch the video without claiming credit.
Differential Diagnosis and Testing for Hematologic Malignancies
With the backdrop of three unique, real-life case studies, learn how to interpret advancements in diagnostic tests used in risk stratification for hematologic malignancies, including next-generation sequencing for the discovery of novel molecular abnormalities as defined by the World Health Organization and European Leukemia Network.
Posted: January 31, 2019 / Expires: January 31, 2020
This certified activity has expired but you may watch the video without claiming credit.
Advancing the Management of Plasma Cell Dyscrasias
Through expert, case-based discussion, learn how to interpret differential diagnoses of plasma cell dyscrasias, implement the recent changes in the clinical management of the spectrum of multiple myeloma, evaluate the risks and benefits of early treatments for smoldering myeloma, and plan management strategies for patients with solitary plasmacytomas and amyloidosis.
Posted: January 31, 2019 / Expires: January 31, 2020
This certified activity has expired but you may watch the video without claiming credit.
Management of Side Effects for Patients Receiving Multimodality Therapy in Thoracic Oncology
Discover strategies to mitigate adverse events (AEs) of checkpoint inhibitors and radiotherapy for patients with thoracic cancer, and review emerging data regarding managing AEs of EGFR and ALK inhibitors.
Posted: January 31, 2019 / Expires: January 31, 2020
This certified activity has expired but you may watch the video without claiming credit.
New Drug Updates in Solid Tumors
Review the pharmacology and approved indications of medications for the management of solid tumors, including pivotal clinical trial data, the signs and symptoms of associated serious or life-threatening adverse effects, and each drug’s impact on advanced practice.
Posted: January 31, 2019 / Expires: January 31, 2020
This certified activity has expired but you may watch the video without claiming credit.
Evolving Therapies in the Clinical Management of Melanoma
Take a deep dive into clinical data supporting immunotherapies and emerging targeted therapies for the treatment of advanced/metastatic melanoma, as well as strategies to manage and mitigate associated adverse events.
Posted: January 31, 2019 / Expires: January 31, 2020
This certified activity has expired but you may watch the video without claiming credit.
Preventing and Treating Venous Thrombosis in Oncology
Discover how to interpret recent findings comparing safety and efficacy of “standard” anticoagulants with those of direct oral anticoagulants (DOACs), evaluate the risks and benefits of treatment of DOACs, and monitor and assess patient response to anticoagulant treatment.
Posted: January 31, 2019 / Expires: January 31, 2020
This certified activity has expired but you may watch the video without claiming credit.
Sequencing Therapies in Renal Cell Carcinoma
Review strategies for how to best utilize immunotherapy in renal cell carcinoma, including tyrosine kinase inhibitors in the adjuvant setting in patients with advanced disease.
Posted: January 31, 2019 / Expires: January 31, 2020
This certified activity has expired but you may watch the video without claiming credit.
KEYNOTE ADDRESS: Integrating Palliative Care Into the Cancer Care Setting: The Role of the Advanced Practitioner
Review the importance of, and barriers to, integrating palliative care throughout the entire continuum of cancer care, along with supporting data and real-life patient stories, as well as the vital role advanced practitioners play in this evolution of care.
